Érika González-Domínguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Érika González-Domínguez has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Carmen Sánchez-Torres
Centro de Investigación en Sanidad Animal, INIA, Valdeolmos, Madrid, Spain
6 shared publications - Angel Luis Corbi
Myeloid Cell Laboratory, Centro de Investigaciones Biológicas, CSIC
2 shared publications José Luis Flores-Sevilla
Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, 07360 Mexico City, Mexico
2 shared publications- Victoria Campos-Peña
Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Ciudad de México 14269, Mexico
2 shared publications - Alma Barajas-Espinosa
Escuela Superior de Huejutla Universidad Autónoma del Estado de Hidalgo Huejutla de Reyes Hidalgo México
1 shared publication - Azucena Salas
Inflammatory Bowel Disease Unit, Hospital Clínic of Barcelona, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 5 January 2026
- Published by Universidad Autonoma del Estado de Hidalgo in Ciencia Huasteca Boletín Científico de la Escuela Superior de Huejutla
- Vol. 14 (27) , 49-51
Bioma, Homeostasis y Microbioma Humano: Interacciones Sistémicas
El cuerpo humano es u como un sistema interconectado de biomas cuya homeostasis depende del equilibrio dinámico entre el huésped y sus ecosistemas microbianos. Esta revisión integra perspectivas ecológicas y biomédicas para describir cómo el microbioma, el viroma y el micobioma influyen en los sistemas endocrino, inmunológico, nervioso y vascular. La dieta, el estilo de vida y los factores ambientales, como la contaminación atmosférica, modulan la composición microbiana, la señalización metabólica y las vías inflamatorias. Adicionalmente, los metabolitos microbianos actúan como moléculas endocrinas y neuroactivas que regulan hormonas, citocinas y neurotransmisores que sostienen el equilibrio fisiológico. Las alteraciones de estas redes conducen a disfunciones sistémicas, mostrando que la salud es una propiedad ecológica emergente del equilibrio entre el organismo humano y sus biomas internos.
- 5 January 2026
- Published by Universidad Autonoma del Estado de Hidalgo in Ciencia Huasteca Boletín Científico de la Escuela Superior de Huejutla
- Vol. 14 (27) , 49-51
Open AccessBioma, Homeostasis y Microbioma Humano: Interacciones Sistémicas
El cuerpo humano es u como un sistema interconectado de biomas cuya homeostasis depende del equilibrio dinámico entre el huésped y sus ecosistemas microbianos. Esta revisión integra perspectivas ecológicas y biomédicas para describir cómo el microbioma, el viroma y el micobioma influyen en los sistemas endocrino, inmunológico, nervioso y vascular. La dieta, el estilo de vida y los factores ambientales, como la contaminación atmosférica, modulan la composición microbiana, la señalización metabólica y las vías inflamatorias. Adicionalmente, los metabolitos microbianos actúan como moléculas endocrinas y neuroactivas que regulan hormonas, citocinas y neurotransmisores que sostienen el equilibrio fisiológico. Las alteraciones de estas redes conducen a disfunciones sistémicas, mostrando que la salud es una propiedad ecológica emergente del equilibrio entre el organismo humano y sus biomas internos.
- Open Access
- 5 January 2023
- Published by Universidad Autonoma del Estado de Hidalgo in Ciencia Huasteca Boletín Científico de la Escuela Superior de Huejutla
- Vol. 11 (21) , 36-38
PICO: Eje central de la Enfermería Basada en la Evidencia y su Relación con el Método Científico
En respuesta a la importancia curricular de la investigación en la Licenciatura de Enfermería y de la creciente participación de los alumnos en la generación de productos de investigación de alto impacto, se ha organizado este mapa conceptual de los aspectos más destacados dentro del proceso de la Enfermería Basada en Evidencia (EBE). El método científico se incorpora en las cinco etapas de la EBE, quedando como eje la pregunta PICO. El proceso de investigación es continuo, ya que la evaluación del mismo conlleva a la formulación de más preguntas clínicas. Dado la creciente población con problemas de salud y la escasez de personal de enfermería que realiza investigación con enfoque directo al bienestar de la comunidad, es de suma importancia impulsar a los futuros profesionistas de la salud para que desarrollen y ejecuten investigación de calidad.
- 5 January 2023
- Published by Universidad Autonoma del Estado de Hidalgo in Ciencia Huasteca Boletín Científico de la Escuela Superior de Huejutla
- Vol. 11 (21) , 36-38
Open AccessPICO: Eje central de la Enfermería Basada en la Evidencia y su Relación con el Método Científico
En respuesta a la importancia curricular de la investigación en la Licenciatura de Enfermería y de la creciente participación de los alumnos en la generación de productos de investigación de alto impacto, se ha organizado este mapa conceptual de los aspectos más destacados dentro del proceso de la Enfermería Basada en Evidencia (EBE). El método científico se incorpora en las cinco etapas de la EBE, quedando como eje la pregunta PICO. El proceso de investigación es continuo, ya que la evaluación del mismo conlleva a la formulación de más preguntas clínicas. Dado la creciente población con problemas de salud y la escasez de personal de enfermería que realiza investigación con enfoque directo al bienestar de la comunidad, es de suma importancia impulsar a los futuros profesionistas de la salud para que desarrollen y ejecuten investigación de calidad.
- Open Access
- 1 February 2016
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 196 (3) , 1327-1337
Atypical Activin A and IL-10 Production Impairs Human CD16+ Monocyte Differentiation into Anti-Inflammatory Macrophages
Human CD14++CD16− and CD14+/loCD16+ monocyte subsets comprise 85 and 15% of blood monocytes, respectively, and are thought to represent distinct stages in the monocyte differentiation pathway. However, the differentiation fates of both monocyte subsets along the macrophage (Mϕ) lineage have not yet been elucidated. We have now evaluated the potential of CD14++ CD16− and CD16+ monocytes to differentiate and to be primed toward pro- or anti-inflammatory Mϕs upon culture with GM-CSF or M-CSF, respectively (subsequently referred to as GM14, M14, GM16, or M16). Whereas GM16 and GM14 were phenotypic and functionally analogous, M16 displayed a more proinflammatory profile than did M14. Transcriptomic analyses evidenced that genes associated with M-CSF–driven Mϕ differentiation (including FOLR2, IL10, IGF1, and SERPINB2) are underrepresented in M16 with respect to M14. The preferential proinflammatory skewing of M16 relative to M14 was found to be mediated by the secretion of activin A and the low levels of IL-10 produced by M16. In fact, activin A receptor blockade during the M-CSF–driven differentiation of CD16+ monocytes, or addition of IL-10–containing M14-conditioned medium, significantly enhanced their expression of anti-inflammatory–associated molecules while impairing their acquisition of proinflammatory-related markers. Thus, we propose that M-CSF drives CD14++CD16ˉ monocyte differentiation into bona fide anti-inflammatory Mϕs in a self-autonomous manner, whereas M-CSF–treated CD16+ monocytes generate Mϕs with a skewed proinflammatory profile by virtue of their high activin A expression unless additional anti-inflammatory stimuli such as IL-10 are provided.
- 1 February 2016
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 196 (3) , 1327-1337
Open AccessAtypical Activin A and IL-10 Production Impairs Human CD16+ Monocyte Differentiation into Anti-Inflammatory Macrophages
Human CD14++CD16− and CD14+/loCD16+ monocyte subsets comprise 85 and 15% of blood monocytes, respectively, and are thought to represent distinct stages in the monocyte differentiation pathway. However, the differentiation fates of both monocyte subsets along the macrophage (Mϕ) lineage have not yet been elucidated. We have now evaluated the potential of CD14++ CD16− and CD16+ monocytes to differentiate and to be primed toward pro- or anti-inflammatory Mϕs upon culture with GM-CSF or M-CSF, respectively (subsequently referred to as GM14, M14, GM16, or M16). Whereas GM16 and GM14 were phenotypic and functionally analogous, M16 displayed a more proinflammatory profile than did M14. Transcriptomic analyses evidenced that genes associated with M-CSF–driven Mϕ differentiation (including FOLR2, IL10, IGF1, and SERPINB2) are underrepresented in M16 with respect to M14. The preferential proinflammatory skewing of M16 relative to M14 was found to be mediated by the secretion of activin A and the low levels of IL-10 produced by M16. In fact, activin A receptor blockade during the M-CSF–driven differentiation of CD16+ monocytes, or addition of IL-10–containing M14-conditioned medium, significantly enhanced their expression of anti-inflammatory–associated molecules while impairing their acquisition of proinflammatory-related markers. Thus, we propose that M-CSF drives CD14++CD16ˉ monocyte differentiation into bona fide anti-inflammatory Mϕs in a self-autonomous manner, whereas M-CSF–treated CD16+ monocytes generate Mϕs with a skewed proinflammatory profile by virtue of their high activin A expression unless additional anti-inflammatory stimuli such as IL-10 are provided.
- 21 May 2015
- Published by Portland Press Ltd. in Clinical Science
- Vol. 129 (4) , 319-330
Diverging biological roles among human monocyte subsets in the context of tuberculosis infection
Circulating monocytes (Mo) play an essential role in the host immune response to chronic infections. We previously demonstrated that CD16pos Mo were expanded in TB (tuberculosis) patients, correlated with disease severity and were refractory to dendritic cell differentiation. In the present study, we investigated whether human Mo subsets (CD16neg and CD16pos) differed in their ability to influence the early inflammatory response against Mycobacterium tuberculosis. We first evaluated the capacity of the Mo subsets to migrate and engage a microbicidal response in vitro. Accordingly, CD16neg Mo were more prone to migrate in response to different mycobacteria-derived gradients, were more resistant to M. tuberculosis intracellular growth and produced higher reactive oxygen species than their CD16pos counterpart. To assess further the functional dichotomy among the human Mo subsets, we carried out an in vivo analysis by adapting a hybrid mouse model (SCID/Beige, where SCID is severe combined immunodeficient) to transfer each Mo subset, track their migratory fate during M. tuberculosis infection, and determine their impact on the host immune response. In M. tuberculosis-infected mice, the adoptively transferred CD16neg Mo displayed a higher lung migration index, induced a stronger pulmonary infiltration of murine leucocytes expressing pro- and anti-inflammatory cytokines, and significantly decreased the bacterial burden, in comparison with CD16pos Mo. Collectively, our results indicate that human Mo subsets display divergent biological roles in the context of M. tuberculosis infection, a scenario in which CD16neg Mo may contribute to the anti-mycobacterial immune response, whereas CD16pos Mo might promote microbial resilience, shedding light on a key aspect of the physiopathology of TB disease.
- 21 May 2015
- Published by Portland Press Ltd. in Clinical Science
- Vol. 129 (4) , 319-330
Diverging biological roles among human monocyte subsets in the context of tuberculosis infection
Circulating monocytes (Mo) play an essential role in the host immune response to chronic infections. We previously demonstrated that CD16pos Mo were expanded in TB (tuberculosis) patients, correlated with disease severity and were refractory to dendritic cell differentiation. In the present study, we investigated whether human Mo subsets (CD16neg and CD16pos) differed in their ability to influence the early inflammatory response against Mycobacterium tuberculosis. We first evaluated the capacity of the Mo subsets to migrate and engage a microbicidal response in vitro. Accordingly, CD16neg Mo were more prone to migrate in response to different mycobacteria-derived gradients, were more resistant to M. tuberculosis intracellular growth and produced higher reactive oxygen species than their CD16pos counterpart. To assess further the functional dichotomy among the human Mo subsets, we carried out an in vivo analysis by adapting a hybrid mouse model (SCID/Beige, where SCID is severe combined immunodeficient) to transfer each Mo subset, track their migratory fate during M. tuberculosis infection, and determine their impact on the host immune response. In M. tuberculosis-infected mice, the adoptively transferred CD16neg Mo displayed a higher lung migration index, induced a stronger pulmonary infiltration of murine leucocytes expressing pro- and anti-inflammatory cytokines, and significantly decreased the bacterial burden, in comparison with CD16pos Mo. Collectively, our results indicate that human Mo subsets display divergent biological roles in the context of M. tuberculosis infection, a scenario in which CD16neg Mo may contribute to the anti-mycobacterial immune response, whereas CD16pos Mo might promote microbial resilience, shedding light on a key aspect of the physiopathology of TB disease.
- 15 April 2015
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 98 (4) , 453-466
CD163L1 and CLEC5A discriminate subsets of human resident and inflammatory macrophages in vivo
Macrophages (Mϕ) can be differentiated and polarized in vitro from human CD14+ monocytes under the influence of GM-CSF (GM-Mϕ) and M-CSF (M-Mϕ). GM-Mϕs are proinflammatory and M-Mϕs have an anti-inflammatory phenotype. We found selective expression of the lectin C-type lectin domain family 5 member A (CLEC5A) transcripts in GM-Mϕs and the scavenger receptor CD163 molecule-like 1 (CD163L1) in M-Mϕs by microarray assay. In vitro, CD163L1 expression was induced by IL-10 and M-CSF and CLEC5A by inflammatory cytokines and cell adherence. In secondary lymphoid organs, their respective expression was restricted to CD68+/CD163+ Mϕs that preferentially produced either TNF (CLEC5A+) or IL-10 (CD163L1+). Mϕs from healthy liver and colon tissue were mostly CD163L1+, and CLEC5A+ cells were scarce. In contrast, CLEC5A+ Mϕs were abundant in the intestinal lamina propria from patients with inflammatory bowel disease (IBD), with higher numbers of CLEC5A+CD163L1+ found compared with those in secondary lymphoid organs. CLEC5A+ cells were CD14+CD209−CD11b+CD11c+TNF+IL-10+, and single positive CD163L1+ cells were CD14−CD209+CD11b−CD11c−TNF−IL-10+ in healthy donors and had lost the ability to produce IL-10 and to express CD209 in those with IBD. In melanomas, CLEC5A+ tumor-associated Mϕs (TAMs) were not detected in 42% of the cases evaluated, but CD163L1+ TAMs were found in 100%. Similar to IBD, CD163L1+ TAMs expressed high levels of CD209 and produced significant amounts of IL-10, and CLEC5A+ TAMs were CD14hi and produced enhanced levels of TNF in metastases. Overall, these results suggest that CD163L1 expression is associated with tissue-resident Mϕs with an anti-inflammatory or anergic phenotype and that CLEC5A+ Mϕs exhibit TNF-producing ability and might display a proinflammatory effect.
- 15 April 2015
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 98 (4) , 453-466
CD163L1 and CLEC5A discriminate subsets of human resident and inflammatory macrophages in vivo
Macrophages (Mϕ) can be differentiated and polarized in vitro from human CD14+ monocytes under the influence of GM-CSF (GM-Mϕ) and M-CSF (M-Mϕ). GM-Mϕs are proinflammatory and M-Mϕs have an anti-inflammatory phenotype. We found selective expression of the lectin C-type lectin domain family 5 member A (CLEC5A) transcripts in GM-Mϕs and the scavenger receptor CD163 molecule-like 1 (CD163L1) in M-Mϕs by microarray assay. In vitro, CD163L1 expression was induced by IL-10 and M-CSF and CLEC5A by inflammatory cytokines and cell adherence. In secondary lymphoid organs, their respective expression was restricted to CD68+/CD163+ Mϕs that preferentially produced either TNF (CLEC5A+) or IL-10 (CD163L1+). Mϕs from healthy liver and colon tissue were mostly CD163L1+, and CLEC5A+ cells were scarce. In contrast, CLEC5A+ Mϕs were abundant in the intestinal lamina propria from patients with inflammatory bowel disease (IBD), with higher numbers of CLEC5A+CD163L1+ found compared with those in secondary lymphoid organs. CLEC5A+ cells were CD14+CD209−CD11b+CD11c+TNF+IL-10+, and single positive CD163L1+ cells were CD14−CD209+CD11b−CD11c−TNF−IL-10+ in healthy donors and had lost the ability to produce IL-10 and to express CD209 in those with IBD. In melanomas, CLEC5A+ tumor-associated Mϕs (TAMs) were not detected in 42% of the cases evaluated, but CD163L1+ TAMs were found in 100%. Similar to IBD, CD163L1+ TAMs expressed high levels of CD209 and produced significant amounts of IL-10, and CLEC5A+ TAMs were CD14hi and produced enhanced levels of TNF in metastases. Overall, these results suggest that CD163L1 expression is associated with tissue-resident Mϕs with an anti-inflammatory or anergic phenotype and that CLEC5A+ Mϕs exhibit TNF-producing ability and might display a proinflammatory effect.
- 1 September 2014
- Published by Elsevier in Clinical Immunology
- Vol. 154 (1) , 72-83
Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients
- 1 September 2014
- Published by Elsevier in Clinical Immunology
- Vol. 154 (1) , 72-83
Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients
- Open Access
- 21 September 2011
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 90 (6) , 1119-1131
Human CD16+ and CD16– monocyte subsets display unique effector properties in inflammatory conditions in vivo
Two major subsets of human Mo are identified based on CD14 and CD16 expression: the classical CD16– Mo and the minor CD14+CD16+ Mo. In vitro studies suggested distinct function and differentiation potential for each cell population. However, the in vivo relevance of these findings remains unclear. To evaluate the development and function of human Mo in an in vivo model, we transferred both Mo subpopulations into the peritoneum of immunocompromised mice in homeostatic or inflammatory conditions. Inflammation was induced with soluble LPS or particulate zymosan. CD16+ were more phagocytic and produced higher amounts of TNF and IL-6 than CD16– Mo early after transfer with zymosan. They also produced higher levels of β2-defensin in any condition evaluated, which could represent a new marker for this subpopulation. In contrast, differentiating CD16– Mo (24 h after transfer) acquired greater APC capacity in LPS-induced peritonitis, whereas none of the Mo subsets attained this ability with zymosan. CX3CL1 supported the survival of both Mo subsets in vivo. Similar Mo subpopulations were present in human peritonitis. These results support the idea of specialized roles of the Mo subset, where CD16+ might act in an immediate innate immune response, whereas CD16– could have a major role as APCs.
- 21 September 2011
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 90 (6) , 1119-1131
Open AccessHuman CD16+ and CD16– monocyte subsets display unique effector properties in inflammatory conditions in vivo
Two major subsets of human Mo are identified based on CD14 and CD16 expression: the classical CD16– Mo and the minor CD14+CD16+ Mo. In vitro studies suggested distinct function and differentiation potential for each cell population. However, the in vivo relevance of these findings remains unclear. To evaluate the development and function of human Mo in an in vivo model, we transferred both Mo subpopulations into the peritoneum of immunocompromised mice in homeostatic or inflammatory conditions. Inflammation was induced with soluble LPS or particulate zymosan. CD16+ were more phagocytic and produced higher amounts of TNF and IL-6 than CD16– Mo early after transfer with zymosan. They also produced higher levels of β2-defensin in any condition evaluated, which could represent a new marker for this subpopulation. In contrast, differentiating CD16– Mo (24 h after transfer) acquired greater APC capacity in LPS-induced peritonitis, whereas none of the Mo subsets attained this ability with zymosan. CX3CL1 supported the survival of both Mo subsets in vivo. Similar Mo subpopulations were present in human peritonitis. These results support the idea of specialized roles of the Mo subset, where CD16+ might act in an immediate innate immune response, whereas CD16– could have a major role as APCs.